My Thoughts and Expressions
To celebrate International Women’s Day 2021, Biocon brought together two of India’s most successful women role models who are an inspiration for today’s generation of girls to become tomorrow’s business leaders. Biocon Executive Chairperson Kiran Mazumdar-Shaw and NASSCOM President Debjani Ghosh participated in a very engaging virtual Fireside Chat on the topic of ‘Women in … Continue reading Women in Leadership: Kiran Mazumdar-Shaw & Debjani Ghosh Engage in a Special Fireside Chat
Kiran Mazumdar-Shaw, Founder & Executive Chairperson, Biocon shares her journey of endurance with young entrepreneurs and students as part of the 'Legends on Unacademy' campaign, which is focussed on motivating the country's youth. She speaks about how she started her journey of making global impact at the young age of 25. How despite her youth, … Continue reading Endurance & Entrepreneurship
By Kiran Mazumdar-Shaw “A ship in port is safe, but that's not what ships are built for,” said Grace Hopper (1906–1992), one of the first programmers in the history of computers. Her belief that programming languages should be as easily understood as English was highly influential on the development of COBOL, one of the first computer … Continue reading We Need More Indian Women to Make a Mark in Science
Kiran Mazumdar-Shaw, Founder & Executive Chairperson, Biocon engages with youth across the country at the Harvard US-India Initiative's 2021 India Conference. In a fireside chat, Kiran covers a diverse array of topics, from India's role in global healthcare, the country’s handling of the coronavirus pandemic, as well as, the future of the biopharmaceutical industry. She … Continue reading India’s role in Global Healthcare
By Kiran Mazumdar-Shaw, Executive Chairperson, Biocon It was very encouraging to see such a pragmatic, growth-focused budget that addresses the key need to boost economic recovery in the aftermath of the COVID-19 impact. This has been reflected in the market cheer following the announcement. The budget covers the major segments which needed redressal with big … Continue reading A Reassuring Budget Focused on Growth, Investment & Jobs
By Kiran Mazumdar-Shaw Chairperson, Biocon Group and member of The Lancet Citizen’s Commission on Re-imagining India’s Health System Technology can enable India to leapfrog into an advanced healthcare system that fulfils the vision of the national health policy of promoting wellness, universal access and affordable care for all Indians. The National Digital Health Mission (NDHM) … Continue reading Budget Push can Transform ASHA Workers from Health Activists to Digital Health Agents to deliver on NDHM
By Kiran Mazumdar-Shaw, Executive Chairperson, Biocon & Biocon Biologics India’s healthcare standards have significantly improved over the past decades. Life expectancy has doubled from 35 years in 1950 to 70 years today. Most infectious diseases have been brought under control. Many key indicators of rural healthcare have also improved: Infant Mortality Rate (IMR) has reduced … Continue reading Economic Liberalisation and the Changing Face of Healthcare in India
Kiran Mazumdar-Shaw Shaw spoke to Barkha Dutt, editor of Mojo, addressing doubts around India's COVID-19 vaccines rollout, on whether India's two approved vaccines are safe, what the difference is in the approval to the Serum Institute and Bharat Biotech vaccines and who should get the vaccines first. Here's Part 2 of the interview. Barkha: Are … Continue reading Decoding India’s Covid Vaccine Approvals with Kiran Mazumdar-Shaw: Part II
Kiran Mazumdar-Shaw Shaw spoke to Barkha Dutt, editor of Mojo, addressing doubts around India's COVID-19 vaccines rollout, on whether India's two approved vaccines are safe, what the difference is in the approval to the Serum Institute and Bharat Biotech vaccines and who should get the vaccines first. Here's Part 1 of the interview. Barkha Dutt: … Continue reading Decoding India’s two approved vaccines and looking at the rollout with Kiran Mazumdar Shaw
India’s health regulator Drugs Controller General of India (DCGI) has granted Emergency Use Authorization (EUA) to two vaccines, Covaxin andCovishield , to fight the COVID-19 pandemic. Covaxin has been developed by Bharat Biotech in collaboration with the Indian Council for Medical Research (ICMR) and National Institute of Virology (NIV). Covishield has been developed by Oxford … Continue reading Indian regulator has granted Emergency Approval to Covaxin, Covishield based on strong scientific judgment.